Live feed08:00:00·8dPRReleaseBoehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine CarcinomasZLAB· Zai Lab LimitedHealth CareOriginal source
